Skip to main content
Top
Published in: Clinical Rheumatology 5/2016

01-05-2016 | Case Based Review

Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome

Authors: Tadashi Nakamura, Kei Hirakawa, Hirokazu Takaoka, Ken-ichi Iyama

Published in: Clinical Rheumatology | Issue 5/2016

Login to get access

Abstract

Dystrophic calcinosis in soft tissue occurs in damaged or devitalized tissues in the presence of normal calcium and phosphorous metabolism. It is often noted in subcutaneous tissues in patients with collagen vascular diseases and may involve a relatively localized area or be widespread. A 74-year-old Japanese woman with an overlap of rheumatoid arthritis, Sjögren’s syndrome, and systemic sclerosis developed a huge tumor-like mass at the atlanto-axial vertebral joint region that caused severe cervical pain and difficulty in activities of daily living. She also had subcutaneous dystrophic calcification in the soft tissue of the chest wall. Calcinosis associated with systemic sclerosis is a well-recognized phenomenon, but a destructive paraspinal tumor in the cervical spine associated with overlap syndrome is extremely unique. Because calcinosis in spinal locations can be complicated by neurological involvement, patients with progressive symptoms may require surgical intervention. Surgical resection and biological therapy improved this patient’s life and activities of daily living. Calcinosis is common in the conditions reviewed here, and different agents have been used for treatment. However, calcinosis management is poorly organized and lacks an accepted classification, systematic studies, and clinical therapeutic trials. The association of calcinosis and collagen vascular diseases is clinically and etiologically important. Although a combination of calcinosis and rheumatoid overlap syndrome is rare, various collagen vascular diseases may occur simultaneously. A perceptive diagnostic approach toward these diseases is critical, and early diagnosis and treatment are needed to prevent dystrophic calcinosis.
Literature
1.
go back to reference Boulman N, Slobodin G, Rozenbaum M, Rosner I (2005) Calcinosis in rheumatic diseases. Semin Arthritis Rheum 34:805–812CrossRefPubMed Boulman N, Slobodin G, Rozenbaum M, Rosner I (2005) Calcinosis in rheumatic diseases. Semin Arthritis Rheum 34:805–812CrossRefPubMed
2.
go back to reference Neumeister MW, Murray KA (1999) Calcinosis of the hand in scleroderma: a case report. Can J Plast Surg 7:241–244 Neumeister MW, Murray KA (1999) Calcinosis of the hand in scleroderma: a case report. Can J Plast Surg 7:241–244
3.
go back to reference Hacihanefioglu U (1978) Tumoral calcinosis. A clinical and pathological study of eleven unreported cases in Turkey. J Bone Joint Surg 60A:1131–1135 Hacihanefioglu U (1978) Tumoral calcinosis. A clinical and pathological study of eleven unreported cases in Turkey. J Bone Joint Surg 60A:1131–1135
4.
5.
go back to reference Durant DM, Riley LH, Burger PC, McCarty EF (2001) Tumoral calcinosis. A study of 21 cases. Spine 26:1673–1679CrossRefPubMed Durant DM, Riley LH, Burger PC, McCarty EF (2001) Tumoral calcinosis. A study of 21 cases. Spine 26:1673–1679CrossRefPubMed
6.
go back to reference Watanabe A, Isobe S, Kaneko M, Nukui H (2000) Tumoral calcinosis of the lumbar meninges: case report. Neurosurgery 47:230–232PubMed Watanabe A, Isobe S, Kaneko M, Nukui H (2000) Tumoral calcinosis of the lumbar meninges: case report. Neurosurgery 47:230–232PubMed
7.
go back to reference Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
8.
go back to reference Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborate initiative. Ann Rheum Dis 69:1580–1588CrossRefPubMed Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborate initiative. Ann Rheum Dis 69:1580–1588CrossRefPubMed
9.
go back to reference Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662CrossRef Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662CrossRef
10.
go back to reference Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral
11.
go back to reference van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral
12.
go back to reference Nakamura T, Higashi S, Tomoda K, Tsukano M, Sugi K (2007) Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjogren’s syndrome and thyroid dysfunction. Clin Rheumatol 26:596–600CrossRefPubMed Nakamura T, Higashi S, Tomoda K, Tsukano M, Sugi K (2007) Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjogren’s syndrome and thyroid dysfunction. Clin Rheumatol 26:596–600CrossRefPubMed
13.
go back to reference Turkcapar N, Olmez U, Oxer D, Duzgun N, Duman M (2006) A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjogren’s syndrome. Rheumatol Int 26:841–845CrossRefPubMed Turkcapar N, Olmez U, Oxer D, Duzgun N, Duman M (2006) A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjogren’s syndrome. Rheumatol Int 26:841–845CrossRefPubMed
15.
16.
go back to reference Maddison PJ (1991) Overlap syndromes and mixed connective tissue disease. Curr Opin Rheumatol 3:995–1000CrossRefPubMed Maddison PJ (1991) Overlap syndromes and mixed connective tissue disease. Curr Opin Rheumatol 3:995–1000CrossRefPubMed
17.
go back to reference Gendi N, Gordon T, Tanner SB, Black CM (1992) The evolution of a case of overlap syndrome with systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus. Br J Rheumatol 31:783–786CrossRefPubMed Gendi N, Gordon T, Tanner SB, Black CM (1992) The evolution of a case of overlap syndrome with systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus. Br J Rheumatol 31:783–786CrossRefPubMed
18.
go back to reference Dahlberg PA, Holmlund G, Karlsson FA, Safwenberg J (1981) HLA-A, -B, -C, and -DR antigens in patients with Graves’ disease and their correlation with signs and clinical course. Acta Endocrinol 97:42–47PubMed Dahlberg PA, Holmlund G, Karlsson FA, Safwenberg J (1981) HLA-A, -B, -C, and -DR antigens in patients with Graves’ disease and their correlation with signs and clinical course. Acta Endocrinol 97:42–47PubMed
19.
go back to reference Dunne J, Lynch S, O’Farrenlly C et al (2001) Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol 167:3129–3138CrossRefPubMed Dunne J, Lynch S, O’Farrenlly C et al (2001) Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol 167:3129–3138CrossRefPubMed
20.
go back to reference Marzano AV, Kolesnikova LV, Gasparini G et al (1999) Dystrophic calcinosis cutis in subacute lupus. Dermatology 198:90–92CrossRefPubMed Marzano AV, Kolesnikova LV, Gasparini G et al (1999) Dystrophic calcinosis cutis in subacute lupus. Dermatology 198:90–92CrossRefPubMed
21.
go back to reference Harigane K, Mochida Y, Ishii K, Ono S, Mistugi N, Saito T (2011) Dystrophic calcinosis in a patient with rheumatoid arthritis. Mod Rheumatol 21:85–88CrossRefPubMed Harigane K, Mochida Y, Ishii K, Ono S, Mistugi N, Saito T (2011) Dystrophic calcinosis in a patient with rheumatoid arthritis. Mod Rheumatol 21:85–88CrossRefPubMed
22.
go back to reference Pursley TV, Prince MJ, Chausmer AB et al (1979) Cutaneous manifestation of tumoral calcinosis. Arch Dermatol 115:1100–1102CrossRefPubMed Pursley TV, Prince MJ, Chausmer AB et al (1979) Cutaneous manifestation of tumoral calcinosis. Arch Dermatol 115:1100–1102CrossRefPubMed
23.
go back to reference Abraham Z, Rozner I, Rozenbaum M (1996) Tumoral calcinosis: report of a case and brief review of the literature. J Dermatol 23:545–550CrossRefPubMed Abraham Z, Rozner I, Rozenbaum M (1996) Tumoral calcinosis: report of a case and brief review of the literature. J Dermatol 23:545–550CrossRefPubMed
24.
go back to reference Laskin WB, Miettinen M, Fetsch JF (2007) Calcaneous lesions of the distal extremities resembling tumoral calcinosis (tumoral calcinosislike lesions): clinicopathologic study of 43 cases emphasizing a pathogenesis-based approach to classification. Am J Surg Pathol 31:15–25CrossRefPubMed Laskin WB, Miettinen M, Fetsch JF (2007) Calcaneous lesions of the distal extremities resembling tumoral calcinosis (tumoral calcinosislike lesions): clinicopathologic study of 43 cases emphasizing a pathogenesis-based approach to classification. Am J Surg Pathol 31:15–25CrossRefPubMed
25.
go back to reference Primetis E, Dalakidis A, Papacharalampous X, Skiadas V, Vlahos L, Gouliamos A (2010) Extensive tumoral calcinosis in a patient with systemic sclerosis. Am J Orthop 39:E108–E110PubMed Primetis E, Dalakidis A, Papacharalampous X, Skiadas V, Vlahos L, Gouliamos A (2010) Extensive tumoral calcinosis in a patient with systemic sclerosis. Am J Orthop 39:E108–E110PubMed
26.
go back to reference Raimer SS (1985) Calcinosis cutis. Curr Concept Skin Dis 6:9–15 Raimer SS (1985) Calcinosis cutis. Curr Concept Skin Dis 6:9–15
27.
go back to reference Black AS, Kanat IO (1985) A review of soft tissue calcifications. J Foot Surg 24:243–250PubMed Black AS, Kanat IO (1985) A review of soft tissue calcifications. J Foot Surg 24:243–250PubMed
28.
go back to reference Wilmer WA, Magro CM (2002) Calciphylaxis emerging concept in prevention, diagnosis, and treatment. Semin Dial 15:172–186CrossRefPubMed Wilmer WA, Magro CM (2002) Calciphylaxis emerging concept in prevention, diagnosis, and treatment. Semin Dial 15:172–186CrossRefPubMed
29.
go back to reference Llamas-Velasco M, Equren C, Santiago D, Garcia-Garcia C, Fraqa J, Garcia-Diez A (2010) Calcinosis cutis and Sjogren’s syndrome. Lupus 19:762–764CrossRefPubMed Llamas-Velasco M, Equren C, Santiago D, Garcia-Garcia C, Fraqa J, Garcia-Diez A (2010) Calcinosis cutis and Sjogren’s syndrome. Lupus 19:762–764CrossRefPubMed
30.
go back to reference Qadri SRM, Choksey MS, Shad A (2005) Tumoural calcinosis of the cervical spine: case report, pathogenesis and differential diagnosis. Br J Neurosurg 19:185–190CrossRefPubMed Qadri SRM, Choksey MS, Shad A (2005) Tumoural calcinosis of the cervical spine: case report, pathogenesis and differential diagnosis. Br J Neurosurg 19:185–190CrossRefPubMed
31.
go back to reference Chikazu D, Mori Y, Saijo H et al (2008) A case of tumoural calcinosis in the temporomandibular joint associated with systemic sclerosis. Int J Oral Maxillofac Surg 37:190–193CrossRefPubMed Chikazu D, Mori Y, Saijo H et al (2008) A case of tumoural calcinosis in the temporomandibular joint associated with systemic sclerosis. Int J Oral Maxillofac Surg 37:190–193CrossRefPubMed
32.
go back to reference Mckee PH, Liomba NG, Hutt MSR (1982) Tumoral calcinosis: a pathological study of fifty-six cases. Br J Dermatol 107:669–674CrossRefPubMed Mckee PH, Liomba NG, Hutt MSR (1982) Tumoral calcinosis: a pathological study of fifty-six cases. Br J Dermatol 107:669–674CrossRefPubMed
33.
go back to reference Fetsch JF, Montgomery EA, Meis JM (1993) Calcifying fibrous pseudotumor. Am J Surg Pathol 17:502–508CrossRefPubMed Fetsch JF, Montgomery EA, Meis JM (1993) Calcifying fibrous pseudotumor. Am J Surg Pathol 17:502–508CrossRefPubMed
34.
go back to reference Teng AL, Robbin MR, Furey CG, Easley SE, Abdul-Karim FW, Bohlman HH (2006) Tumoral calcinosis in the cervical spine in a patient with CREST syndrome. J Bone Joint Surg 88A:193–197CrossRef Teng AL, Robbin MR, Furey CG, Easley SE, Abdul-Karim FW, Bohlman HH (2006) Tumoral calcinosis in the cervical spine in a patient with CREST syndrome. J Bone Joint Surg 88A:193–197CrossRef
35.
go back to reference Rutsch F, Terkeltaub R (2003) Parallels between arterial and cartilage calcification: what understanding artery calcification can teach us about chondrocalcinosis. Curr Opin Rheumatol 15:302–310CrossRefPubMed Rutsch F, Terkeltaub R (2003) Parallels between arterial and cartilage calcification: what understanding artery calcification can teach us about chondrocalcinosis. Curr Opin Rheumatol 15:302–310CrossRefPubMed
36.
go back to reference Pugashetti R, Shinkai K, Ruben BS, Grossman ME, Maldonado J, Fox LP (2011) Calcium may preferentially deposit in areas of elastic tissue damage. J Am Acad Dermatol 64:296–301CrossRefPubMed Pugashetti R, Shinkai K, Ruben BS, Grossman ME, Maldonado J, Fox LP (2011) Calcium may preferentially deposit in areas of elastic tissue damage. J Am Acad Dermatol 64:296–301CrossRefPubMed
37.
go back to reference Vayssairat M, Hidouche D, Abdoucheli-Baudor N, Gaitz JP (1998) Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression? Ann Rheum Dis 57:252–254CrossRefPubMedPubMedCentral Vayssairat M, Hidouche D, Abdoucheli-Baudor N, Gaitz JP (1998) Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression? Ann Rheum Dis 57:252–254CrossRefPubMedPubMedCentral
38.
go back to reference Marie I, Duparc F, Janvresse A, Levesque H, Courtois H (2004) Tumoral calcinosis in systemic sclerosis. Clin Exp Rheumatol 22:269PubMed Marie I, Duparc F, Janvresse A, Levesque H, Courtois H (2004) Tumoral calcinosis in systemic sclerosis. Clin Exp Rheumatol 22:269PubMed
39.
go back to reference Arginteanu MS, Perin NI (1997) Paraspinal calcinosis associated with progressive systemic sclerosis. J Neurosurg 87:761–763CrossRefPubMed Arginteanu MS, Perin NI (1997) Paraspinal calcinosis associated with progressive systemic sclerosis. J Neurosurg 87:761–763CrossRefPubMed
40.
go back to reference Schweitzer ME, Cervilla V, Manaster BJ et al (1991) Cervical paraspinal calcification in collagen vascular diseases. Am J Radiol 157:523–525 Schweitzer ME, Cervilla V, Manaster BJ et al (1991) Cervical paraspinal calcification in collagen vascular diseases. Am J Radiol 157:523–525
41.
go back to reference Mukamel M, Horev G, Mimouni M (2001) New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 138:763–766CrossRefPubMed Mukamel M, Horev G, Mimouni M (2001) New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 138:763–766CrossRefPubMed
42.
go back to reference Al-Najjar M, Jackson MJ (2011) Non-healing leg ulcers in a patient with dystrophic calcification and CREST syndrome: a challenging clinical case. Int Wound J 8:537–541CrossRefPubMed Al-Najjar M, Jackson MJ (2011) Non-healing leg ulcers in a patient with dystrophic calcification and CREST syndrome: a challenging clinical case. Int Wound J 8:537–541CrossRefPubMed
43.
go back to reference Shibuya S, Kawaguchi Y, Arima N, Yamamoto T, Dobashi H, Tokuda M (2006) Tumoral calcinosis in bilateral facet joints of the lumbar spine in scleroderma. Case report. J Neurosurg Spine 5:451–454CrossRefPubMed Shibuya S, Kawaguchi Y, Arima N, Yamamoto T, Dobashi H, Tokuda M (2006) Tumoral calcinosis in bilateral facet joints of the lumbar spine in scleroderma. Case report. J Neurosurg Spine 5:451–454CrossRefPubMed
44.
go back to reference Dutz J (2000) Treatment options for the cutaneous manifestation of systemic sclerosis. Skin Ther Lett 6:3–5 Dutz J (2000) Treatment options for the cutaneous manifestation of systemic sclerosis. Skin Ther Lett 6:3–5
45.
go back to reference Kalajian AH, Perryman JH, Callen JP (2009) Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands. Arch Dermatol 145:334PubMed Kalajian AH, Perryman JH, Callen JP (2009) Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands. Arch Dermatol 145:334PubMed
46.
go back to reference Smack D, Norton SA, Fitzpatric JE (1996) Proposal for pathogenesis-based classification of tumoral calcinosis. Int J Dermatol 35:265–271CrossRefPubMed Smack D, Norton SA, Fitzpatric JE (1996) Proposal for pathogenesis-based classification of tumoral calcinosis. Int J Dermatol 35:265–271CrossRefPubMed
47.
go back to reference King JJ, Brennan KB, Crawford EA, Fox EJ, Ogilvie CM (2011) Surgical complications associated with extensive tumoral calcinosis. Am J Orthop 40:247–252PubMed King JJ, Brennan KB, Crawford EA, Fox EJ, Ogilvie CM (2011) Surgical complications associated with extensive tumoral calcinosis. Am J Orthop 40:247–252PubMed
48.
go back to reference Smucker JD, Heller JG, Bohlman HH, Whitesides TE Jr (2006) Surgical treatment of destructive calcific lesions of the cervical spine in scleroderma: case series and review of the literature. Spine 31:2002–2008CrossRefPubMed Smucker JD, Heller JG, Bohlman HH, Whitesides TE Jr (2006) Surgical treatment of destructive calcific lesions of the cervical spine in scleroderma: case series and review of the literature. Spine 31:2002–2008CrossRefPubMed
49.
go back to reference Bisson-Vaivre A, Somon T et al (2013) Cervical spinal calcinosis in a patient with systemic sclerosis. Diagn Interv Imaging 94:645–647CrossRefPubMed Bisson-Vaivre A, Somon T et al (2013) Cervical spinal calcinosis in a patient with systemic sclerosis. Diagn Interv Imaging 94:645–647CrossRefPubMed
Metadata
Title
Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome
Authors
Tadashi Nakamura
Kei Hirakawa
Hirokazu Takaoka
Ken-ichi Iyama
Publication date
01-05-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2696-x

Other articles of this Issue 5/2016

Clinical Rheumatology 5/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.